Lifestyle, HealthyRESTARTNCT06122441
RE-inventing Strategies for Healthy Ageing; Recommendations and Tools
A study testing Complex lifestyle intervention and Physical activity monitoring and recommendations in people with Lifestyle, Healthy and Muscle Weakness, run by University of Tromso at 1 site in Norway.
Trial summary
The goal of the RESTART RCT is to examine whether a complex lifestyle intervention, coordinated with municipal and non-government organizations (NGO), can establish and preserve improvements in risk factors and functional capacity among older adults at high risk of cardiometabolic disease. Read more about this study
- Who is it for?
- Ages 60 to 75 years
- Conditions the study is for
- Lifestyle, Healthy, Muscle Weakness, Abdominal Obesity
- What is being tested?
- Complex lifestyle intervention and Physical activity monitoring and recommendations
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 119 participants
- Where
- 1 siteNorway
- Study dates
- 15 Jan 2024to 30 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 60-75 years
- BMI ≥ 30 kg/m2
- Elevated CVD-risk (Score 8/12 on the NORRISK 2 model)
- Sedentary lifestyle (Score "1" on the Saltin-Grimby Physical Activity Level Scale)
Who cannot join
- Presence of dementia diagnosis
- Self-reported previous myocardial infarction or stroke, and/or self-reported established cardiovascular disease by presence of coronary stent
- Heart failure with ejection fraction <50%
- Electrocardiogram ECG presenting with atrioventricular block grade 2 type 2 or grade 3, or previous myocardial infarction.
- Uncontrolled hypertension (systolic blood pressure≥180 mmHg and/or diastolic blood pressure≥110 mmHg unless cleared by a nephrologist)
- Chronic obstructive pulmonary disease grade 3 or 4
Show all 16Show fewer
- Thyroid dysfunction (thyroxine <7 pmol/L and thyroid-stimulating hormone >10 mIU/L, and/or thyroxine >25 pmol/L and thyroid-stimulating hormone <0.2 mIU/L)
- Liver dysfunction (alanine aminotransferase >210 µmol/L for men, >135 µmol/L for women, and/or aspartate aminotransferase >135 µmol/L for men, >105 µmol/L for women, and/or alkaline phosphatase >345 µmol/L)
- Kidney dysfunction (creatinine >220 µmol/L), in addition to prognosis of CKD by GFR and Albuminuria KDIGO 2012 algorithm
- Severe anemia (hemoglobin <10g/dL for men, <8g/dL for women)
- Uncontrolled diabetes (glycated hemoglobin ≥86 mmol/mol)
- Severe hearing problems
- Severe mobility limitations (unable to get up from a sitting or lying position, unable to maintain a crouched position, unable to raise arms above shoulder or head height)
- No possession of a smartphone
- No access to the Norwegian national identification service (BankID)
- Unable to follow the trial regimen for 24 months
Trial locations and contacts
1 site in 1 country.
About this study
Official title: RE-inventing Strategies for Healthy Ageing; Recommendations and Tools (RESTART) - a Randomized Controlled Trial Testing a Complex Lifestyle Intervention in Older Adults at Increased Risk for Cardiometabolic Disease
The goal of the RESTART RCT is to examine whether a complex lifestyle intervention, coordinated with municipal and non-government organizations (NGO), can establish and preserve improvements in risk factors and functional capacity among older adults at high risk of cardiometabolic disease. The main objectives to investigate are whether a complex lifestyle intervention, compared to an active control group, will at 24 months have:
- Produced a clinically relevant increase in cardiorespiratory fitness (primary endpoint)
- Increased muscle strength, physical activity and reduced adiposity
- Improved body composition, health-related quality of life and cognitive function
All participants (Control and Intervention Groups) are provided with wrist-worn activity trackers at baseline and access to national recommendations on physical activity. The intervention group additionally advances through a comprehensive lifestyle program including high-intensity aerobic and strength exercise, dietary and behavioral counselling. Intervention participants are gradually transitioned into exercise activities organized by Tromsø Municipaity and local NGO:s. Testing of outcomes are performed at baseline, 6, 12 and 24 months. Primary endpoint (VO2max) is assessed at 24 months.
Read the detailed description
The proportion of older individuals worldwide is growing, posing a significant challenge to western societies. To address the health challenges of the aging population, primary prevention efforts should focus on various lifestyle factors simultaneously. However, many interventions fail to maintain improved lifestyle habits among participants, highlighting the need for novel and complex approaches to ensure healthy aging among older adults.
The RESTART randomized controlled trial aims to investigate whether participants undergoing a complex lifestyle intervention improve their cardiorespiratory fitness, muscle strength, physical activity, adiposity and body composition, quality of life and cognitive function at 24 months, compared to active controls.
The study and data collection will occur in Tromsø, Norway (pop. 77,000). Participants will receive the intervention at a local community exercise center near the University of Tromsø campus area. Testing of physical performance will take place at the UiT Faculty of Health Sciences research laboratory for sports, physical activity, and public health. The Clinical Trial Unit (CTU) at the local university hospital will additionally oversee clinical examinations, collection of questionnaire data, and blood sampling.
At baseline, both the Control and Intervention Groups are given wrist-worn activity trackers and access to national physical activity recommendations. The Intervention Group also undergoes a comprehensive lifestyle program that includes high-intensity aerobic and strength exercises, as well as dietary and behavioral counseling. The Intervention Group is gradually introduced to exercise activities organized by Tromsø Municipality and local NGOs. Outcome testing is conducted at baseline, 6, 12, and 24 months, with the primary endpoint (VO2max) assessed at 24 months.
Intervention participants will be divided into 4 groups of 12-15 participants each and perform high-intensity training to target the cardiovascular system and skeletal muscle force-generating capacity. For 12 months, the intervention group performs supervised indoor cycling or outdoor hill interval training twice a week at a relatively high intensity (≥85% of maximal heart rate during 4x4 minutes) separated by active rest periods at approximately 70% of maximal heart rate. Immediately after the aerobic exercise, participants perform strength training (3 sets of 5 repetitions) involving leg-press, lateral pull-down, and chest press exercises, with an intensity corresponding to ≥80% of their maximal strength. From months 6-12, one of the two weekly exercise sessions will be led by the Healthy Life Center (HLC; "Frisklivssentralen"), enabling a transition to supervised exercise via the Tromsø municipality primary health care. Between month 12-18, the HLC continue to supervise the participants during one weekly exercise sessions, while they are additionally introduced to exercise activities arranged by local NGO:s.
From month 3 to 12, participants will receive behavioral counseling based on the Acceptance and Commitment Therapy (ACT) approach during six 2-hour group sessions. The individual approach aims to enhance participants' capacity to manage challenging cognitive and emotional experiences, foster psychological flexibility and distress tolerance skills, and promote the development of self-efficacy and new behavior patterns that align with their life values.
From month 6 to 12, the intervention group will receive four dietary counseling sessions based on Norwegian nutritional guidelines. Two individual sessions will involve food diaries, while two group sessions with a partner will focus on basic nutritional information and practical food preparation. The objective is to promote a healthy, sustainable, and personalized diet while promoting increased protein intake, reducing the consumption of high-energy-dense foods and drinks with low nutritional value.
Beginning from month 12 and onwards throughout the trial, the intervention group will be granted access to the Re-start eTool (https://re-start.no/), which is specifically tailored to older adults. The eTool offers concise and easy-to-understand articles, videos, and self-assessment tools that promote physical activity, healthy dietary habits, and behavioral strategies from the complex intervention. The Re-start eTool aims to provide support and reminders to participants as they gradually transition to independently maintaining the achieved lifestyle habits and physical capacity levels.
Throughout the study period, the intervention instructors and assessors monitor potential adverse events during the exercise and testing phases, and all adverse events are reported to the study coordinator. Measures to mitigate adverse events include: 1) insurance of participants via The Norwegian System of Patient Injury Compensation; 2) involving a MD with sports medicine specialization to ensure treatment of potential injuries; 3) pilot study experiences show that short-term alternative exercises are effective in managing exercise-induced pain and discomfort.
- Conditions
- Lifestyle, Healthy, Muscle Weakness, Abdominal Obesity, Cardiometabolic Syndrome, Self Efficacy, Diet, Healthy
- Being tested
- Complex lifestyle intervention, Physical activity monitoring and recommendations
- Keywords
- Complex lifestyle intervention, Older adults, Cardiometabolic risk factors, Cardiorespiratory fitness, Muscle strength, Physical activity, Abdominal obesity, Acceptance and commitment therapy, Health-related quality of life, Cognitive function
- Medical subject headings
- Muscle Weakness, Obesity, Abdominal, Metabolic Syndrome, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Complex lifestyle interventionBehavioural
The complex lifestyle intervention comprise high-intensity aerobic and strength exercise, behavioral counselling based on Acceptance and Commitment Theory (ACT), and dietary counselling based on Norwegian nutritional guidelines. The different intervention elements are introduced step-wise to reduce initial overload. Participants are progressively transitioned over to the Tromsø municipality and local NGO's, who delivers activities harmonized with the intervention elements. Participants are at this stage also supported by an eTool which digitally reinforces the intervention through web-based information and videos.
Physical activity monitoring and recommendationsBehavioural
Wrist-worn activity trackers that are worn throughout the trial, which monitors steps, activity intensity and energy expenditure. Access to Norwegian physical activity guidelines via the Directorate of Health.
| Study group | Role | What they receive |
|---|---|---|
| Complex lifestyle intervention | Experimental | Receives a complex lifestyle intervention, a wrist-worn activity tracker, and access to national recommendations on physical activity. Receives: Behavioral: Complex lifestyle intervention; Behavioral: Physical activity monitoring and recommendations |
| Active control | Active comparator | Receives a wrist-worn activity tracker and access to national recommendations on physical activity. Receives: Behavioral: Physical activity monitoring and recommendations |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in VO2max at month 24
Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.
Measured: Baseline and month 24
Change from baseline in VO2max at month 12
Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.
Measured: Baseline and month 12
Change from baseline in VO2max at month 6
Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.
Measured: Baseline and month 6
Secondary outcomes (16)
Change from baseline in muscle strength at month 24
Assessed as the highest kg achieved during a 1-repetition maximum test in leg-press and chest-press apparatuses.
Measured: Baseline and month 24
Change from baseline in muscle strength at month 12
Assessed as the highest kg achieved during a 1-repetition maximum test in leg-press and chest-press apparatuses.
Measured: Baseline and month 12
Change from baseline in muscle strength at month 6
Assessed as the highest kg achieved during a 1-repetition maximum test in leg-press and chest-press apparatuses.
Measured: Baseline and month 6
Change from baseline in muscle power at month 24
Assessed as power (W; force x speed of contraction) during leg-press exercise with pre-defined weight ascertained during baseline measurements
Measured: Baseline and month 24
Change from baseline in muscle power at month 12
Assessed as power (W; force x speed of contraction) during leg-press exercise with pre-defined weight ascertained during baseline measurements
Measured: Baseline and month 12
Change from baseline in muscle power at month 6
Assessed as power (W; force x speed of contraction) during leg-press exercise with pre-defined weight ascertained during baseline measurements
Measured: Baseline and month 6
Change from baseline in waist circumference at month 24
Assessed in centimeters at the umbilical level (between crista iliaca and the lower rib) using a measurement tape.
Measured: Baseline and month 24
Change from baseline in waist circumference at month 12
Assessed in centimeters at the umbilical level (between crista iliaca and the lower rib) using a measurement tape.
Measured: Baseline and month 12
Change from baseline in waist circumference at month 6
Assessed in centimeters at the umbilical level (between crista iliaca and the lower rib) using a measurement tape.
Measured: Baseline and month 6
Change from baseline in body weight at month 24
Assessed in kilograms using a SECA personal weight. Participants are measured without outdoor clothing and shoes.
Measured: Baseline and month 24
Change from baseline in body weight at month 12
Assessed in kilograms using a SECA personal weight. Participants are measured without outdoor clothing and shoes.
Measured: Baseline and month 12
Change from baseline in body weight at month 6
Assessed in kilograms using a SECA personal weight. Participants are measured without outdoor clothing and shoes.
Measured: Baseline and month 6
Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 24
Assessed as minutes in light, moderate and vigorous intensity, using triaxial accelerometers worn at the hip for 7 days.
Measured: Baseline and month 24
Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 12
Assessed as minutes in light, moderate and vigorous intensity, using triaxial accelerometers worn at the hip for 7 days.
Measured: Baseline and month 12
Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 6
Assessed as minutes in light, moderate and vigorous intensity, using triaxial accelerometers worn at the hip for 7 days.
Measured: Baseline and month 6
Daily physical activity pattern
Asessed using wrist-worn smartwatches that are worn by the participants continously and measures steps, activity intensity and energy expenditure
Measured: 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Nov 2023
- Study start15 Jan 2024
- Primary completion30 Jun 2026 (estimated)
- Study completion30 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Lifestyle, HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- RESTART is designed as a two-arm, single blind, parallel group RCT, with a 1:1 allocation ratio into either intervention or active control group
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 119 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Tromso
- Sponsor type
- University, hospital or other
- Collaborators
- The Research Council of Norway, Novo Nordisk A/S, Tromso Municipality, University Hospital of North Norway, University of Oslo, Molde University College, National Association for Heart and Lung Diseases, Tromso, Norway, Norwegian Trekking Association, KRAFT Sports Center
- Responsible party
- Sponsor
- Investigators
- Sameline Grimsgaard, PhD, Principal investigator, UiT The Arctic University of NorwayJonas Johansson, PhD, Study director, UiT The Arctic University of NorwayTrygve Deraas, PhD, Study director, UiT The Arctic University of NorwayCamilla Flåten, MSc, Study director, UiT The Arctic University of NorwayAndré Henriksen, PhD, Study director, UiT The Arctic University of NorwayLaila Hopstock, PhD, Study director, UiT The Arctic University of Norway
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06122441
- Sponsor's protocol ID
- 2023/584841(REK)
- Other IDs
- 2023
- Acronym
- RESTART
- Status last verified
- Apr 2026
- First submitted
- 26 Oct 2023
- Last updated
- 29 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The principal investigators will have access to the final, complete trial dataset. Other investigators can apply to the steering committee for data and may receive access to data with variables specific to the research question of interest.
Publications
Johansson J, Deraas TS, Hopstock LA, Henriksen A, Grimsgaard S. Improving and preserving cardiorespiratory fitness, muscle strength and adiposity through a complex lifestyle intervention in community-dwelling older adults with elevated cardiometabolic risk: study protocol for the RESTART randomised controlled trial. BMJ Open. 2025 Apr 19;15(4):e095810. doi: 10.1136/bmjopen-2024-095810.
PubMed 40254301
Study at a glance
From the registry record, last updated by the sponsor on 29 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- RE-inventing Strategies for Healthy Ageing; Recommendations and Tools (RESTART) - a Randomized Controlled Trial Testing a Complex Lifestyle Intervention in Older Adults at Increased Risk for Cardiometabolic Disease
- ClinicalTrials.gov ID
- NCT06122441
- Acronym / sponsor ID
- RESTART / 2023/584841(REK)
- Conditions
- Lifestyle, Healthy, Muscle Weakness, Abdominal Obesity, Cardiometabolic Syndrome, Self Efficacy, Diet, Healthy
- Keywords
- Complex lifestyle intervention, Older adults, Cardiometabolic risk factors, Cardiorespiratory fitness, Muscle strength, Physical activity, Abdominal obesity, Acceptance and commitment therapy
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 119 participants (actual)
- Lead sponsor
- University of TromsoUniversity, hospital or other
- Collaborators
- The Research Council of Norway, Novo Nordisk A/S, Tromso Municipality, University Hospital of North Norway, University of Oslo, Molde University College, National Association for Heart and Lung Diseases, Tromso, Norway, Norwegian Trekking Association, KRAFT Sports Center
- Study start
- 15 Jan 2024 (actual)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 30 Jun 2027 (estimated)
- First posted
- 8 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of the RESTART RCT is to examine whether a complex lifestyle intervention, coordinated with municipal and non-government organizations (NGO), can establish and preserve improvements in risk factors and functional capacity among older adults at high risk of cardiometabolic disease. The main objectives to investigate are whether a complex lifestyle intervention, compared to an active control group, will at 24 months have:
- Produced a clinically relevant increase in cardiorespiratory fitness (primary endpoint)
- Increased muscle strength, physical activity and reduced adiposity
- Improved body composition, health-related quality of life and cognitive function
All participants (Control and Intervention Groups) are provided with wrist-worn activity trackers at baseline and access to national recommendations on physical activity. The intervention group additionally advances through a comprehensive lifestyle program including high-intensity aerobic and strength exercise, dietary and behavioral counselling. Intervention participants are gradually transitioned into exercise activities organized by Tromsø Municipaity and local NGO:s. Testing of outcomes are performed at baseline, 6, 12 and 24 months. Primary endpoint (VO2max) is assessed at 24 months.
Detailed description
The proportion of older individuals worldwide is growing, posing a significant challenge to western societies. To address the health challenges of the aging population, primary prevention efforts should focus on various lifestyle factors simultaneously. However, many interventions fail to maintain improved lifestyle habits among participants, highlighting the need for novel and complex approaches to ensure healthy aging among older adults.
The RESTART randomized controlled trial aims to investigate whether participants undergoing a complex lifestyle intervention improve their cardiorespiratory fitness, muscle strength, physical activity, adiposity and body composition, quality of life and cognitive function at 24 months, compared to active controls.
The study and data collection will occur in Tromsø, Norway (pop. 77,000). Participants will receive the intervention at a local community exercise center near the University of Tromsø campus area. Testing of physical performance will take place at the UiT Faculty of Health Sciences research laboratory for sports, physical activity, and public health. The Clinical Trial Unit (CTU) at the local university hospital will additionally oversee clinical examinations, collection of questionnaire data, and blood sampling.
At baseline, both the Control and Intervention Groups are given wrist-worn activity trackers and access to national physical activity recommendations. The Intervention Group also undergoes a comprehensive lifestyle program that includes high-intensity aerobic and strength exercises, as well as dietary and behavioral counseling. The Intervention Group is gradually introduced to exercise activities organized by Tromsø Municipality and local NGOs. Outcome testing is conducted at baseline, 6, 12, and 24 months, with the primary endpoint (VO2max) assessed at 24 months.
Intervention participants will be divided into 4 groups of 12-15 participants each and perform high-intensity training to target the cardiovascular system and skeletal muscle force-generating capacity. For 12 months, the intervention group performs supervised indoor cycling or outdoor hill interval training twice a week at a relatively high intensity (≥85% of maximal heart rate during 4x4 minutes) separated by active rest periods at approximately 70% of maximal heart rate. Immediately after the aerobic exercise, participants perform strength training (3 sets of 5 repetitions) involving leg-press, lateral pull-down, and chest press exercises, with an intensity corresponding to ≥80% of their maximal strength. From months 6-12, one of the two weekly exercise sessions will be led by the Healthy Life Center (HLC; "Frisklivssentralen"), enabling a transition to supervised exercise via the Tromsø municipality primary health care. Between month 12-18, the HLC continue to supervise the participants during one weekly exercise sessions, while they are additionally introduced to exercise activities arranged by local NGO:s.
From month 3 to 12, participants will receive behavioral counseling based on the Acceptance and Commitment Therapy (ACT) approach during six 2-hour group sessions. The individual approach aims to enhance participants' capacity to manage challenging cognitive and emotional experiences, foster psychological flexibility and distress tolerance skills, and promote the development of self-efficacy and new behavior patterns that align with their life values.
From month 6 to 12, the intervention group will receive four dietary counseling sessions based on Norwegian nutritional guidelines. Two individual sessions will involve food diaries, while two group sessions with a partner will focus on basic nutritional information and practical food preparation. The objective is to promote a healthy, sustainable, and personalized diet while promoting increased protein intake, reducing the consumption of high-energy-dense foods and drinks with low nutritional value.
Beginning from month 12 and onwards throughout the trial, the intervention group will be granted access to the Re-start eTool (https://re-start.no/), which is specifically tailored to older adults. The eTool offers concise and easy-to-understand articles, videos, and self-assessment tools that promote physical activity, healthy dietary habits, and behavioral strategies from the complex intervention. The Re-start eTool aims to provide support and reminders to participants as they gradually transition to independently maintaining the achieved lifestyle habits and physical capacity levels.
Throughout the study period, the intervention instructors and assessors monitor potential adverse events during the exercise and testing phases, and all adverse events are reported to the study coordinator. Measures to mitigate adverse events include: 1) insurance of participants via The Norwegian System of Patient Injury Compensation; 2) involving a MD with sports medicine specialization to ensure treatment of potential injuries; 3) pilot study experiences show that short-term alternative exercises are effective in managing exercise-induced pain and discomfort.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- RESTART is designed as a two-arm, single blind, parallel group RCT, with a 1:1 allocation ratio into either intervention or active control group
| Arm | Type | Receives |
|---|---|---|
| Complex lifestyle intervention | Experimental | Behavioral: Complex lifestyle intervention, Behavioral: Physical activity monitoring and recommendationsReceives a complex lifestyle intervention, a wrist-worn activity tracker, and access to national recommendations on physical activity. |
| Active control | Active comparator | Behavioral: Physical activity monitoring and recommendationsReceives a wrist-worn activity tracker and access to national recommendations on physical activity. |
Who may qualify
- Ages
- 60 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Age 60-75 years
- BMI ≥ 30 kg/m2
- Elevated CVD-risk (Score 8/12 on the NORRISK 2 model)
- Sedentary lifestyle (Score "1" on the Saltin-Grimby Physical Activity Level Scale)
Key exclusion criteria (16 listed)
- Presence of dementia diagnosis
- Self-reported previous myocardial infarction or stroke, and/or self-reported established cardiovascular disease by presence of coronary stent
- Heart failure with ejection fraction <50%
- Electrocardiogram ECG presenting with atrioventricular block grade 2 type 2 or grade 3, or previous myocardial infarction.
- Uncontrolled hypertension (systolic blood pressure≥180 mmHg and/or diastolic blood pressure≥110 mmHg unless cleared by a nephrologist)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Complex lifestyle interventionThe complex lifestyle intervention comprise high-intensity aerobic and strength exercise, behavioral counselling based on Acceptance and Commitment Theory (ACT), and dietary counselling based on Norwegian nutritional guidelines. The different intervention elements are introduced step-wise to reduce initial overload. Participants are progressively transitioned over to the Tromsø municipality and local NGO's, who delivers activities harmonized with the intervention elements. Participants are at this stage also supported by an eTool which digitally reinforces the intervention through web-based information and videos. | Behavioural | Complex lifestyle intervention |
| Physical activity monitoring and recommendationsWrist-worn activity trackers that are worn throughout the trial, which monitors steps, activity intensity and energy expenditure. Access to Norwegian physical activity guidelines via the Directorate of Health. | Behavioural | Active control, Complex lifestyle intervention |
Primary outcome
Change from baseline in VO2max at month 24
Time frame: Baseline and month 24
Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.
Change from baseline in VO2max at month 12
Time frame: Baseline and month 12
Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.
Change from baseline in VO2max at month 6
Time frame: Baseline and month 6
Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.
16 secondary outcomes
Change from baseline in muscle strength at month 24
Time frame: Baseline and month 24
Change from baseline in muscle strength at month 12
Time frame: Baseline and month 12
Change from baseline in muscle strength at month 6
Time frame: Baseline and month 6
Change from baseline in muscle power at month 24
Time frame: Baseline and month 24
Change from baseline in muscle power at month 12
Time frame: Baseline and month 12
Change from baseline in muscle power at month 6
Time frame: Baseline and month 6
Change from baseline in waist circumference at month 24
Time frame: Baseline and month 24
Change from baseline in waist circumference at month 12
Time frame: Baseline and month 12
Change from baseline in waist circumference at month 6
Time frame: Baseline and month 6
Change from baseline in body weight at month 24
Time frame: Baseline and month 24
Change from baseline in body weight at month 12
Time frame: Baseline and month 12
Change from baseline in body weight at month 6
Time frame: Baseline and month 6
Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 24
Time frame: Baseline and month 24
Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 12
Time frame: Baseline and month 12
Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 6
Time frame: Baseline and month 6
Daily physical activity pattern
Time frame: 24 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2026.
- Derived from this study: PubMed 40254301Johansson J, Deraas TS, Hopstock LA, Henriksen A, Grimsgaard S. Improving and preserving cardiorespiratory fitness, muscle strength and adiposity through a complex lifestyle intervention in community-dwelling older adults with elevated cardiometabolic risk: study protocol for the RESTART randomised controlled trial. BMJ Open. 2025 Apr 19;15(4):e095810. doi: 10.1136/bmjopen-2024-095810.
- Project webpage (only currently available in Norwegian)Link provided by the sponsor.
- Individual participant dataSharing planned: Yes. The principal investigators will have access to the final, complete trial dataset. Other investigators can apply to the steering committee for data and may receive access to data with variables specific to the research question of interest.
Related trials for Lifestyle, Healthy
Recruiting
Yoga vs. Stretching-Strengthening: Physical Fitness in Sedentary Young Adults
Sedentary Lifestlye, Exercise
Active, not recruiting
Italian Digital Primary Cardiovascular Prevention Study
Healthy Population
Active, not recruiting
Healthy for my Baby- RCT of a Lifestyle Intervention for Overweight Women in Preconception
Overweight and Obesity, Pregnancy Complications
Recruiting
LIfestyle MEtabotype Study B (LIME-B)
Nutritional and Metabolic Diseases, Prediabetes
Recruiting
Implementation of a Multiple Intervention to Promote Healthy Lifestyles in Patients With Depression
Major Depressive Disorder (MDD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sameline Grimsgaard, PhD principal investigator
UiT The Arctic University of Norway
Jonas Johansson, PhD study director
UiT The Arctic University of Norway
Trygve Deraas, PhD study director
UiT The Arctic University of Norway
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Complex lifestyle intervention and Physical activity monitoring and recommendations in people with Lifestyle, Healthy and Muscle Weakness, run by University of Tromso at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in VO2max at month 24 (time frame: Baseline and month 24). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06122441, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.